50.85
-4.62 (-8.33%)
Penutupan Terdahulu | 55.47 |
Buka | 55.27 |
Jumlah Dagangan | 1,436,810 |
Purata Dagangan (3B) | 738,917 |
Modal Pasaran | 3,764,257,792 |
Harga / Jualan (P/S) | 1.99 |
Harga / Buku (P/B) | 4.00 |
Julat 52 Minggu | |
Tarikh Pendapatan | 6 May 2025 - 12 May 2025 |
Margin Keuntungan | 0.15% |
Margin Operasi (TTM) | 6.23% |
EPS Cair (TTM) | 0.040 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 13.50% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -81.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 152.54% |
Nisbah Semasa (MRQ) | 2.12 |
Aliran Tunai Operasi (OCF TTM) | 233.02 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 51.06 M |
Pulangan Atas Aset (ROA TTM) | 2.35% |
Pulangan Atas Ekuiti (ROE TTM) | 3.99% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Diagnostics & Research (US) | Menurun | Menurun |
Diagnostics & Research (Global) | Menurun | Menurun | |
Stok | RadNet, Inc. | Menaik | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 3.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 4.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -2.0 |
Purata | 2.00 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment. |
|
Sektor | Healthcare |
Industri | Diagnostics & Research |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 10.43% |
% Dimiliki oleh Institusi | 88.29% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 80.00 (Jefferies, 57.33%) | Beli |
Median | 69.50 (36.68%) | |
Rendah | 60.00 (Barclays, 17.99%) | Beli |
Purata | 69.75 (37.17%) | |
Jumlah | 4 Beli | |
Harga Purata @ Panggilan | 53.84 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Truist Securities | 11 Apr 2025 | 74.00 (45.53%) | Beli | 48.70 |
22 Jan 2025 | 88.00 (73.06%) | Beli | 63.73 | |
Barclays | 24 Mar 2025 | 60.00 (17.99%) | Beli | 51.83 |
22 Jan 2025 | 74.00 (45.53%) | Beli | 63.73 | |
Raymond James | 05 Mar 2025 | 65.00 (27.83%) | Beli | 53.09 |
Jefferies | 15 Jan 2025 | 80.00 (57.33%) | Beli | 61.74 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |